Acurx Pharmaceuticals, Inc. Reports Second Quarter Results and Provides Business Update
STATEN ISLAND, N.Y., Aug. 12, 2025 /PRNewswire/ -- Acurx Pharmaceuticals, Inc. (NASDAQ: ACXP) ("Acurx" or the "Company"), a late-stage biopharmaceutical company developing a new class of antibiotic...
17 days ago